Principal Investigator
Navya Nair
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251179
Clinical Trial Summary
A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Gynecologic Cancer
Contact Information
Phone Number
305-243-2647